Escitalopram
- Product NDC
- 51655-147
- Requested package NDC
- 51655-147-26
- 11-digit product format
- 516550147
- Labeler code
- 51655
- Product ID
- 51655-147_48c3e3f2-09c4-c403-e063-6294a90aafde
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Escitalopram Oxalate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA090432
- Marketing category
- ANDA
- Marketing start
- 2023-01-25
- Substance
- ESCITALOPRAM OXALATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090432-001 | ESCITALOPRAM OXALATE | ESCITALOPRAM OXALATE | EQ 5MG BASE | TABLET / ORAL | AB | 2012-09-11 | |
| A090432-002 | ESCITALOPRAM OXALATE | ESCITALOPRAM OXALATE | EQ 10MG BASE | TABLET / ORAL | AB | 2012-09-11 | |
| A090432-003 | ESCITALOPRAM OXALATE | ESCITALOPRAM OXALATE | EQ 20MG BASE | TABLET / ORAL | AB | 2012-09-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090432-001 | AB |
| A090432-002 | AB |
| A090432-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090432-001 | ESCITALOPRAM OXALATE | EQ 5MG BASE | TABLET / ORAL | AB | 2012-09-11 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090432-002 | ESCITALOPRAM OXALATE | EQ 10MG BASE | TABLET / ORAL | AB | 2012-09-11 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090432-003 | ESCITALOPRAM OXALATE | EQ 20MG BASE | TABLET / ORAL | AB | 2012-09-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090432-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090432-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090432-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Escitalopram | ESCITALOPRAM OXALATE | PD-Rx Pharmaceuticals, Inc. | 517a551a-6f60-4b8d-9341-63a41baff12d | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | Bryant Ranch Prepack | ee5963ad-3b53-48e5-b7a9-b13af5740ef1 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | St. Mary's Medical Park Pharmacy | 09945404-e4cf-6269-e063-6294a90a5b8d | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | Aurobindo Pharma Limited | d5fbc8ce-bd41-4bd0-b413-0dea97e596c3 | 2026-05-12 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | Asclemed USA, Inc. | 2957a003-7714-4e16-aeca-623fd6c5d702 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | Northwind Health Company, LLC | f6ca64ec-68ff-e1ea-e053-6294a90ae0f8 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 51655-147-26 51655-147 51655014726 |
| Escitalopram | ESCITALOPRAM OXALATE | QPharma, Inc. | 85fbcce8-a870-4f04-8a0e-a12e46eed3cf | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | American Health Packaging | 3019a647-9bcf-48cf-928c-0467f9b921a8 | 2025-03-21 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | NCS HealthCare of KY, LLC dba Vangard Labs | b29ae169-d60b-464a-9763-f1d8d9e0598d | 2025-01-24 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | A-S Medication Solutions | b85ef018-0217-4ddf-885d-206acc0a5f84 | 2024-04-30 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | Advanced Rx Pharmacy of Tennessee, LLC | 138f8703-2f13-6d07-e063-6394a90a4413 | 2024-03-19 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | NCS HealthCare of KY, LLC dba Vangard Labs | ac9ede0c-7912-4e7d-83b3-964feee61215 | 2023-07-20 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | A-S Medication Solutions | 10b25a10-c5e7-479b-a9f5-7eeafd802323 | 2023-04-16 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | Proficient Rx LP | 52df055d-b1c8-4de2-8545-ef08b5bf9c39 | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
| Escitalopram | ESCITALOPRAM OXALATE | Proficient Rx LP | 2d0b4839-e4d1-4e0e-9dc0-ba821f266472 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 090432 ANDA090432 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Escitalopram
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ESCITALOPRAM OXALATE | 20 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5U85DBW7LO | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 351250 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f6ca64ec-68ff-e1ea-e053-6294a90ae0f8 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 04dce598-23c6-b7e7-c3dd-9b9cfd6e1615 | Product name | 6 | 20170718 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51655-147-26 | Escitalopram | 90 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 90 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 351250 | escitalopram oxalate 20 MG Oral Tablet | PSN | f6ca64ec-68ff-e1ea-e053-6294a90ae0f8 | 4 |
| 351250 | escitalopram 20 MG Oral Tablet | SCD | f6ca64ec-68ff-e1ea-e053-6294a90ae0f8 | 4 |
| 351250 | escitalopram (as escitalopram oxalate) 20 MG Oral Tablet | SY | f6ca64ec-68ff-e1ea-e053-6294a90ae0f8 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 51655-147-26 | 51655014726 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-147-26) | 2023-01-25 | No | No | Current |